Following the Food and Drug Administration (FDA) Konkan division's decision to suspend Cipla's Patalganga production unit license for 10 days in December 2023 due to non-compliance with the 1940 Drugs and Cosmetics Act's good manufacturing practices requirements, Cipla's shares experienced a more than 1% drop in early trade on August 17.
The suspension order comes as a consequence of the facility's failure to adhere to regulatory standards, impacting Cipla's reputation and investor sentiment. Despite this setback, Cipla expressed disagreement with the FDA's decision and the provided justifications, leading the company to initiate an appeal with the state government.
Despite the negative impact on stock prices, Cipla assured investors that the suspension will not significantly affect financial results or business operations, seeking to allay concerns. Furthermore, recent reports suggest that global private equity firm Blackstone has engaged in discussions to acquire the stake held by Cipla's promoters, the Hamied family.
Although Cipla has labeled these speculations as market rumors, the anticipation of private equity involvement has propelled the pharmaceutical company's stock price by nearly 20% over the past month.
For feedback and suggestions, feel free to reach us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.